Magnetization transfer changes of grey and white matter in Parkinson's disease
暂无分享,去创建一个
V. Gallai† | G. Pelliccioli | G. Montanari | N. Tambasco | P. Chiarini | V. Gallai | G. P. Pelliccioli | P. Chiarini | N. Tambasco | G. E. Montanari | F. Leone | M. L. Mancini | M. Paciaroni | F. Leone | M. Paciaroni | M. Mancini | Maurizio Paciaroni | N. Tambasco | Giorgio E. Montanari | V. Gallai
[1] R M Henkelman,et al. MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. , 1993, AJNR. American journal of neuroradiology.
[2] W. M. van der Flier,et al. Magnetization transfer imaging in normal aging, mild cognitive impairment, and Alzheimer's disease , 2002, Annals of neurology.
[3] P. Pahapill,et al. The pedunculopontine nucleus and Parkinson's disease. , 2000, Brain : a journal of neurology.
[4] C. Marsden,et al. Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease , 1989, Journal of neurochemistry.
[5] R I Grossman,et al. Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes , 1989, Neurology.
[6] Hirofumi Sakurai,et al. Magnetization transfer ratio in cerebral white matter lesions of Binswanger’s disease , 1999, Journal of the Neurological Sciences.
[7] B. L. Miller,et al. The Neuropathology of Parkinsonism - An Overview , 1995, Brain and Cognition.
[8] K. Jellinger,et al. Iron‐Melanin Complex in Substantia Nigra of Parkinsonian Brains: An X‐Ray Microanalysis , 1992, Journal of neurochemistry.
[9] J. Degroot,et al. Magnetic resonance imaging of the midbrain in Parkinson's disease , 1986, Annals of neurology.
[10] P. Ryvlin,et al. Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson's disease. , 1995, Archives of neurology.
[11] V. Mathews,et al. Cranial tissues: appearance at gadolinium-enhanced and nonenhanced MR imaging with magnetization transfer contrast. , 1994, Radiology.
[12] R. Ordidge,et al. Increased iron‐related MRI contrast in the substantia nigra in Parkinson's disease , 1995, Neurology.
[13] K. Jellinger,et al. The pathology of Parkinson's disease. , 2001, Advances in neurology.
[14] G B Pike,et al. Measure of magnetization transfer in multiple sclerosis demyelinating plaques, white matter ischemic lesions, and edema. , 1996, AJNR. American journal of neuroradiology.
[15] A. Lees,et al. Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.
[16] F. Tison,et al. Oral zolmitriptan is effective in the acute treatment of cluster headache , 2000, Neurology.
[17] G J Barker,et al. Magnetisation transfer ratio of normal brain white matter: a normative database spanning four decades of life. , 1997, Journal of neurology, neurosurgery, and psychiatry.
[18] T. Hosoya,et al. Evaluation of the substantia nigra in patients with Parkinsonian syndrome accomplished using multishot diffusion-weighted MR imaging. , 1999, AJNR. American journal of neuroradiology.
[19] E. Hirsch,et al. Glial cell participation in the degeneration of dopaminergic neurons in Parkinson's disease. , 1999, Advances in neurology.
[20] D Gadian,et al. Does signal-attenuation on high-field T2-weighted MRI of the brain reflect regional cerebral iron deposition? Observations on the relationship between regional cerebral water proton T2 values and iron levels. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[21] S. Fahn,et al. Study of movement disorders and brain iron by MR. , 1987, AJR. American journal of roentgenology.
[22] C. Good,et al. Differentiation of atypical parkinsonian syndromes with routine MRI , 2000, Neurology.
[23] R M Henkelman,et al. Relaxivity and magnetization transfer of white matter lipids at MR imaging: importance of cerebrosides and pH. , 1994, Radiology.
[24] C. Olanow. A radical hypothesis for neurodegeneration , 1993, Trends in Neurosciences.
[25] P. Piccini,et al. White Matter Hyperintensities in Parkinson's Disease: Clinical Correlations , 1995 .
[26] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[27] A. Okumura,et al. The characterization of human brain tumor using magnetization transfer technique in magnetic resonance imaging. , 1999, Neurological research.
[28] R. Grossman,et al. MR imaging of Parkinson disease with spin-echo and gradient-echo sequences. , 1988, AJR. American journal of roentgenology.
[29] C Trenkwalder,et al. The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy? , 1999, Archives of neurology.
[30] P. Boesiger,et al. T2 relaxation time in patients with Parkinson's disease , 1993, Neurology.
[31] M Cercignani,et al. Reproducibility of magnetization transfer ratio histogram-derived measures of the brain in healthy volunteers. , 2000, AJNR. American journal of neuroradiology.
[32] Rahul C. Mehta,et al. Magnetization Transfer Magnetic Resonance Imaging: A Clinical Review , 1996, Topics in magnetic resonance imaging : TMRI.
[33] S. T. G. Roup,et al. DEEP-BRAIN STIMULATION OF THE SUBTHALAMIC NUCLEUS OR THE PARS INTERNA OF THE GLOBUS PALLIDUS IN PARKINSON'S DISEASE , 2001 .
[34] J C Gore,et al. The role of specific side groups and pH in magnetization transfer in polymers. , 1998, Journal of magnetic resonance.
[35] R P Maguire,et al. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease. , 1997, Brain : a journal of neurology.
[36] R E Lenkinski,et al. Magnetization transfer imaging and proton MR spectroscopy in the evaluation of axonal injury: correlation with clinical outcome after traumatic brain injury. , 2001, AJNR. American journal of neuroradiology.
[37] Howard Chertkow,et al. Regional magnetization transfer ratio changes in mild cognitive impairment , 2002, Magnetic resonance in medicine.
[38] R S Balaban,et al. Lipid bilayer and water proton magnetization transfer: Effect of cholesterol , 1991, Magnetic resonance in medicine.
[39] T. Parrish,et al. Contrast-enhanced magnetization transfer MR of the brain: importance of precontrast images. , 1997, AJNR. American journal of neuroradiology.
[40] S. Gilman,et al. Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.
[41] G. Paulson,et al. Magnetic resonance imaging in Parkinson's disease. , 1990, Archives of neurology.
[42] R. Grossman,et al. Magnetization transfer imaging of periventricular hyperintense white matter in the elderly. , 1995, AJNR. American journal of neuroradiology.
[43] I. Steiner,et al. Features of brain atrophy in Parkinson's disease , 1985, Neuroradiology.
[44] T Ernst,et al. Progressive multifocal leukoencephalopathy and human immunodeficiency virus-associated white matter lesions in AIDS: magnetization transfer MR imaging. , 1999, Radiology.
[45] M Takasaki,et al. Magnetization transfer measurements of the hippocampus in patients with Alzheimer's disease, vascular dementia, and other types of dementia. , 2000, AJNR. American journal of neuroradiology.
[46] M Konagaya,et al. Clinical and magnetic resonance imaging study of extrapyramidal symptoms in multiple system atrophy. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[47] S. Fahn. Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .
[48] G. Allan Johnson,et al. Magnetic Resonance Imaging of Brain Iron , 1986 .
[49] P. Krack,et al. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. , 2001, The New England journal of medicine.
[50] G. B. Pike,et al. Magnetization transfer MR of the normal adult brain. , 1995, AJNR. American journal of neuroradiology.
[51] P Riederer,et al. Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains , 1991, Journal of neurochemistry.
[52] R. Balaban,et al. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo , 1989, Magnetic resonance in medicine.
[53] M Hutchinson,et al. Parkinson's disease: a novel MRI method for determining structural changes in the substantia nigra , 1999, Journal of neurology, neurosurgery, and psychiatry.
[54] T. Gasser. Molecular genetics of Parkinson's disease. , 2001, Advances in neurology.
[55] M. Skalej,et al. Magnetic resonance imaging–based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy , 1999, Annals of neurology.
[56] S. Heiland,et al. Magnetization transfer measurements in normal-appearing cerebral white matter in patients with chronic obstructive hydrocephalus. , 1999, Journal of computer assisted tomography.
[57] H. Hanyu,et al. Magnetisation transfer measurements of the subcortical grey and white matter in Parkinson's disease with and without dementia and in progressive supranuclear palsy , 2001, Neuroradiology.
[58] G J Barker,et al. In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging , 2000, Journal of neurology, neurosurgery, and psychiatry.
[59] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.